Skip to content

Rafi Allos



Allos Rafi
Rafi Allos



Rafi specialises in life sciences patents litigation and advising clients on regulatory issues in the life sciences sector. Rafi's patent litigation experience includes both representing clients in U.K. proceedings and assisting clients with multi-jurisdictional proceedings and preparation for potential litigation. In addition, Rafi has a particular interest on the interplay between life sciences regulatory issues and patent litigation and in regulatory exclusivities.

Rafi has spoken on life sciences regulatory matters at the Pharmaceutical Law Academy in Cambridge from 2014 to 2017. He has been recognised since 2017 as a "rising star" in the Patents section of Managing Intellectual Property's IP Stars and as a Next Generation Lawyer/Rising Star in Legal 500 (both in Life Sciences and Healthcare and in Patents). Rafi was also awarded a European Rising Star Award in the Life Sciences and UK categories in the Euromoney LMG Europe Rising Star Awards 2019.

Related articles

medicine; medical device

Blog Post: 22 March 2023

Clinical Trial Regulation: A streamlined reform of the UK Clinical Trials Regulatory Framework - new measures published

The MHRA announced on Tuesday the biggest overhaul of clinical trial regulation in the UK in 20 years. The details of the amendments to clinical trial regulation are set out in the MHRA’s response to…

Read more

Blog Post: 02 March 2023

The Windsor Framework: MHRA to have power to licence all types of medicines to be supplied in the United Kingdom in single pack

Read more

Blog Post: 28 November 2022

Webinar - EU developments in pricing and reimbursement

Read more

Blog Post: 28 October 2022

EC Decision reliance procedure for GB Marketing Authorisations extended by MHRA for one year to 31 December 2023

Read more

Experience highlights



One Bishops Square
E1 6AD

View office →



Solicitor-Advocate (Higher Courts Civil Proceedings), 2018

Admitted as solicitor, England and Wales, 2013 


BA (First Class Hons), Jurisprudence (Law), University of Oxford, 2009

Postgraduate Diploma in Intellectual Property Law and Practice (Distinction), University of Oxford, 2014

Other noteworthy experience


  • Global pharmaceutical company on innovator patent disputes in multiple jurisdictions involving its blockbuster monoclonal antibody drug.
  • Global pharmaceutical company on the defence of its blockbuster small molecule drug against generic competition in the UK.
  • A European pharmaceutical company on its patent litigation strategy, co-ordinating six European jurisdictions.
  • LEO Pharma on the defence of its patents on Dovobet® (calcipotriol/betamethasone ointment) for the treatment of psoriasis.
  • Various life sciences companies on regulatory matters including on data exclusivity issues; routes for obtaining marketing authorisations; biosimilars; the regulation of clinical trials; compassionate use programmes; paediatric rewards; SPCs; parallel imports; the Specific Mechanism; borderline products; and the medical devices regulatory regime.